ENTRY       D11893                      Drug
NAME        Bintrafusp alfa (USAN/INN);
            Bintrafusp alfa (genetical recombination) (JAN)
FORMULA     C7780H12056N2092O2490S78
EXACT_MASS  177125.9283
MOL_WEIGHT  177236.563
SEQUENCE    (Heavy chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFTFS SYIMMWVRQA PGKGLEWVSS IYPSGGITFY
            ADTVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARIK LGTVTTVDYW GQGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
            MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPGA GGGGSGGGGS GGGGSGGGGS GIPPHVQKSV
            NNDMIVTDNN GAVKFPQLCK FCDVRFSTCD NQKSCMSNCS ITSICEKPQE VCVAVWRKND
            ENITLETVCH DPKLPYHDFI LEDAASPKCI MKEKKKPGET FFMCSCSSDE CNDNIIFSEE
            YNTSNPD
            (Light chain)
            QSALTQPASV SGSPGQSITI SCTGTSSDVG GYNYVSWYQQ HPGKAPKLMI YDVSNRPSGV
            SNRFSGSKSG NTASLTISGL QAEDEADYYC SSYTSSSTRV FGTGTKVTVL GQPKANPTVT
            LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADGSPVK AGVETTKPSK QSNNKYAASS
            YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECS
            (Disulfide bridge: H22-H96, H147-H203, H223-L215, H229^H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'215, H'264-H'324, H'370-H'428, L22-L90, L138-L197, L'22-L'90, L'138-L'197)
  TYPE      Peptide
CLASS       Antineoplastic
             DG02938  Immune checkpoint inhibitor
EFFICACY    Antineoplastic
COMMENT     Bifunctional fusion protein
TARGET      PDL1 (CD274) [HSA:29126] [KO:K06745]
            TGFBR2 [HSA:7048] [KO:K04388]
  PATHWAY   hsa04060(7048)  Cytokine-cytokine receptor interaction
            hsa04350(7048)  TGF-beta signaling pathway
            hsa04514(29126)  Cell adhesion molecules
            hsa05235(29126)  PD-L1 expression and PD-1 checkpoint pathway in cancer
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG02938  Immune checkpoint inhibitor
               D11893  Bintrafusp alfa
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor serine/threonine kinases (RSTK)
               TGFBR2 family
                TGFBR2
                 D11893  Bintrafusp alfa (USAN/INN)
             Cell surface molecules and ligands
              Other cell surface molecules
               Immune checkpoints
                PDL1 (CD274)
                 D11893  Bintrafusp alfa (USAN/INN)
DBLINKS     CAS: 1918149-01-5
///
